
AccuStem to launch MSC blood test for lung cancer screening in US
AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes. The company aims to broaden the test’s use to the 15 million individuals who are at risk and those who are eligible for lung …